Frontiers in Anti-Infective Drug Discovery: Volume 2

(6)
Frontiers in Anti-Infective Drug Discovery: Volume 2 image
ISBN-10:

1608058611

ISBN-13:

9781608058617

Released: Feb 08, 2018
Format: Paperback, 416 pages
Related ISBN: 9781681082929

Description:

“Frontiers in Anti-Infective Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Infective drug design and discovery. Eminent scientists write contributions in all areas of rational drug design and drug discovery, including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Infective drug design and discovery. Each volume is devoted to the major advances in Anti-Infective drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Best prices to buy, sell, or rent ISBN 9781608058617




Frequently Asked Questions about Frontiers in Anti-Infective Drug Discovery: Volume 2

You can buy the Frontiers in Anti-Infective Drug Discovery: Volume 2 book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $126.87 on Amazon and is available from 1 sellers at the moment.

If you’re interested in selling back the Frontiers in Anti-Infective Drug Discovery: Volume 2 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Frontiers in Anti-Infective Drug Discovery: Volume 2 book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.